test

Zhanping Wu

@Vivo Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$1.208BTotal holdings43
Assets growth rate11.63%Assets growth rate (2-Q avg)-1.65%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Vivo Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 43 positions.

Assets under management

The assets under management (AUM) of Vivo Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.208B in assets, with a quarterly growth rate of 11.63% and a 2-quarter average growth rate of -1.65%. The portfolio is managed by Zhanping Wu, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SLNOSoleno Therapeutics Inc
Recent Activity
Decreased -14%
26.3%
$317.676M
6.292M shares@ $50.5 avg price
DYNDyne Therapeutics Inc
Recent Activity
Decreased -31.81%
3.32%
$40.049M
1.115M shares@ $35.92 avg price
OLMAOlema Pharmaceuticals Inc
Recent Activity
Decreased -19.63%
1.49%
$17.98M
1.506M shares@ $11.94 avg price
ATXSAstria Therapeutics Inc
Recent Activity
Decreased -33.33%
1.42%
$17.095M
1.553M shares@ $11.02 avg price
COGTCogent Biosciences Inc
Recent Activity
Decreased -49.99%
1.01%
$12.123M
1.122M shares@ $10.81 avg price
DCTHDelcath Systems, Inc.
Recent Activity
Decreased -40.18%
0.75%
$9.003M
997,005 shares@ $9.03 avg price
ALXOAlx Oncology Holdings Inc
Recent Activity
Decreased -4.39%
0.61%
$7.343M
4.035M shares@ $1.82 avg price
ALLKAllakos Inc
Recent Activity
Decreased -1.06%
0.16%
$1.931M
2.956M shares@ $0.66 avg price